W. Wallace Harrington

Author

Also Known As

W Harrington, W W Harrington, W. W. Harrington, W. Wallace Harrington, W. Wallace Harrington,, W.W. Harrington, Wallace Harrington

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Research Triangle Park Foundation GlaxoSmithKline (United States)GlaxoSmithKline (Netherlands)GlaxoSmithKline (India)Duke Medical Center

About

W. Wallace Harrington is an author at Research Triangle Park Foundation specializing in medicine, pharmacology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	1.4K
2	Health Sciences	4	4	617
3	Natural Sciences	2	2	426
4	Public Health	1	1	113
5	Social Sciences	1	1	139

W. Wallace Harrington

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Adipose Tissue Resistin Expression Is Severely Suppressed in Obesity and Stimulated by Peroxisome Proliferator-activated Receptor γ Agonists James M. Way, Cem Z. Görgün, Qiang Tong, Journal of Biological Chemistry	2001	411
Comprehensive Messenger Ribonucleic Acid Profiling Reveals That Peroxisome Proliferator-Activated Receptor γ Activation Has Coordinate Effects on Gene Expression in Multiple Insulin-Sensitive Tissues James M. Way, W. Wallace Harrington, Kathleen K. Brown, Endocrinology GeneticsInsulin SignalingMetabolic SyndromeTranscriptional RegulationMetabolism	2001	343
<i>N</i>-(2-Benzoylphenyl)-<scp>l</scp>-tyrosine PPARγ Agonists. 1. Discovery of a Novel Series of Potent Antihyperglycemic and Antihyperlipidemic Agents Brad R. Henke, Steven G. Blanchard, Marcus F. Brackeen, Journal of Medicinal Chemistry Pharmaceutical SciencePharmacotherapyHeterocycle ChemistryPharmaceutical ChemistryPotent Antihyperglycemic	1998	299
A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat. Kathleen K. Brown, Brad R. Henke, Steven G. Blanchard, Diabetes Insulin SignalingPeroxisome Proliferator-activated ReceptorMetabolic SyndromeDiabetic PhenotypeHealth Sciences	1999	168
High-affinity neuropeptide Y receptor antagonists. Alex J. Daniels, Jessica Matthews, Ruta Slepetis, Proceedings of the National Academy of Sciences NeuropeptidesSympathetic Nerve TerminalsPharmacotherapySocial SciencesAlpha-adrenergic Pharmacology	1995	139
Discovery, Synthesis, and Biological Evaluation of Thiazoloquin(az)olin(on)es as Potent CD38 Inhibitors Curt D. Haffner, J. David Becherer, Eric E. Boros, Journal of Medicinal Chemistry Antiparasitic AgentNad LevelsPharmacotherapyMedicinal ChemistryNad Elevation	2015	127
Formaldehyde concentrations in the blood of rhesus monkeys after inhalation exposure M. Casanova, Henry d’A. Heck, Jeffrey I. Everitt, Food and Chemical Toxicology Animal PhysiologyAllergyRhesus MonkeysRespiratory ToxicologyFormaldehyde Concentrations	1988	113
Regulation of peroxisome proliferator-activated receptor-γ in liver fibrosis Liu Yang, Che–Chang Chan, Ohsang Kwon, American Journal of Physiology-Gastrointestinal and Liver Physiology	2006	108
Pressure, volume, and chemosensitivity in afferent innervation of urinary bladder in rats Nicholas Moss, W. Wallace Harrington, M. S. Tucker American Journal of Physiology-Regulatory, Integrative and Comparative Physiology	1997	81
GI262570, a Peroxisome Proliferator-Activated Receptor γ Agonist, Changes Electrolytes and Water Reabsorption from the Distal Nephron in Rats Lihong Chen, Baichun Yang, Judi A. McNulty, Journal of Pharmacology and Experimental Therapeutics	2005	75

Page 1